FIGHT-202 data: pemigatinib for previously treated locally advanced/metastatic cholangiocarcinoma VJOncology 2:14 4 years ago 709 Далее Скачать
Final results from FIGHT-202: pemigatinib for patients with FGFR-mutated advanced cholangiocarcinoma VJOncology 3:30 2 years ago 326 Далее Скачать
The rapid growth of FGFR2 inhibitors: pemigatinib in FIGHT-202 VJOncology 2:40 3 years ago 280 Далее Скачать
Impact of prior systemic therapy on PFS patients enrolled in FIGHT-202 VJOncology 2:15 3 years ago 70 Далее Скачать
FDA Approved Pemigatinib new drug for cholangiocarcinoma, $18, 448 For 14 Days, But I'm 2 Die 2 I Have Stage IV Cancer Hilar Cholangiocarcinoma 3:29 1 year ago 40 Далее Скачать
Transplant for Perihilar Cholangiocarcinoma Journal of the American College of Surgeons 2:04 4 years ago 139 Далее Скачать
The promise of pemigatinib for patients with FGFR1-rearranged MLN VJHemOnc – Video Journal of Hematology & HemOnc 1:38 2 years ago 293 Далее Скачать
Promising future for cholangiocarcinoma diagnosis and treatment VJOncology 2:11 2 years ago 353 Далее Скачать
Building on our current treatments – is precision medicine the future for CCA? AMMF UK 21:14 3 years ago 196 Далее Скачать
Therapeutic Management of Biliary Cancers: Integrating Precision Medicine With Targeted Strategies PeerView Oncology 21:57 3 years ago 173 Далее Скачать
New compound shows promise in fighting multiple myeloma Research Square 1:39 2 years ago 36 Далее Скачать
